Delivery Order SPE2DB24D2101-SPE2DB24FKFJZ

Award Date 7/22/24
Potential Completion Date 7/23/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,876.00, is a firm fixed-price Delivery Order for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product. The contract has an ultimate completion date of August 1, 2024. Amerisourcebergen, through its Corporate Office division, is the prime contractor on this award and is not operating under a set-aside...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of AMLOD-VALSA-HCTZ 10-320-25 MG 30S medication. The contract has a ceiling value of $1,806.66 and is a Firm Fixed Price Delivery Order that will be completed by September 13, 2024. Amerisourcebergen, through its Corporate Office Division, has been awarded this contract to supply the requested pharmaceutical product to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,897.80 firm fixed-price delivery order covers the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a medical product, with a completion date of December 26, 2023. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,772.55, is a Firm Fixed Price Delivery Order with a completion date of February 3, 2025. The award covers the procurement of pharmaceutical products, including AMLOD-VALSA-HCTZ 10-320-25 MG 30S. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The $2,537.58 firm fixed-price contract is for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S pharmaceutical products, with a period of performance through July 2024. As a major distributor of pharmaceutical and medical supplies, Amerisourcebergen leverages its extensive supply chain to...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AMLOD-VALSA-HCTZ 10-320-25 MG 30S pharmaceutical products. The $4,554.93 contract has a completion date of February 23, 2024 and was awarded on February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order contract is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of AMLOD-VALSA-HCTZ 10-320-25 MG 30S medication. The $1,054.44 firm fixed-price delivery order has a completion date of September 3, 2024 and does not utilize a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,453.31 firm fixed-price delivery order is for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S medication and has a performance period ending on May 16, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,710.37 firm fixed-price delivery order is for the supply of Amlodipine-Valsartan 5-160 mg medication in 30-count packages. The contract has an ultimate completion date of October 11, 2024 and does not utilize any set-aside designations. Amerisourcebergen is one of the largest pharmaceutical distributors in the United...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, identified as SPE2DB20D3103|SPE2DB24FM1Z7, is a Delivery Order valued at $2,855.90 for the supply of AMLOD-VALSA-HCTZ 5-160-12.5 MG 30S pharmaceutical products. The contract has a firm fixed-price pricing type and an ultimate completion date of January 10, 2024. This award is not designated as a set-aside...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB24FKFJZ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The award, valued at $1,520.85, is for the delivery of AMLOD-VALSA-HCTZ 10-320-25 MG 30S pharmaceutical products. The contract has a firm fixed-price delivery order structure and an ultimate completion date of July 23, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a range of medications, medical supplies, and equipment to support various government healthcare programs and military treatment facilities. This award is part of the company's extensive Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive portfolio of medical commodities. The contract does not have a set-aside designation.

Generated 10/21/24, 9:41 AM